Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
33 studies found for:    " March 20, 2013":" April 19, 2013"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Show Display Options
Rank Status Study
21 Completed
Has Results
Bioequivalence Study of Individual Atazanavir and Cobicistat Compared With Atazanavir in Fixed-dose Combination With Cobicistat
Condition: Human Immunodeficiency Virus Type 1 (HIV-1)
Interventions: Drug: Atazanavir;   Drug: Cobicistat;   Drug: Atazanavir/Cobicistat FDC
22 Completed A Prospective, With One Site, Open-label Not Controled Trial, for the Observation of Treatment With CIDOFOVIR 1%, 3 Nights Per Week, During 4 Weeks, of Anal Intraepithelial Neoplasia, High Level, in HIV+ Patients
Condition: HIV
Intervention: Drug: Cidofovir 1% cream's basis, 2gr, three times per week, during 4 weeks.
23 Completed
Has Results
A Two Way Cross Over Pharmacokinetic Interaction Study Between Raltegravir and Amlodipine in Healthy Volunteers
Condition: HIV
Interventions: Drug: Raltegravir;   Drug: Amlodipine
24 Active, not recruiting Pilot Study of Lubiprostone as a Modulator of Gut Microbial Translocation and Systemic Immune Activation in HIV-Infected Persons With Incomplete CD4+ T-cell Recovery on Antiretroviral Therapy
Condition: HIV
Intervention: Drug: Lubiprostone
25 Unknown  Cambodia Integrated HIV and Drug Prevention Implementation Program
Condition: HIV
Intervention: Behavioral: Contingency Cash Transfer
26 Not yet recruiting Impact of a Raltegravir-based Regimen on Early Mortality of Severely Immunocompromised AIDS Patients
Condition: Severely Immunocompromised HIV Patients
Interventions: Drug: Use of Raltegravir-based regimens;   Drug: Efavirenz-based regimens
27 Completed Risky Decision Making in Methamphetamine Users: The Role of Opioid Blockade
Conditions: Methamphetamine Abuse;   HIV
Interventions: Drug: Extended release naltrexone;   Drug: Placebo
28 Recruiting Brief Intervention for Rural Women at High Risk for HIV/HCV
Conditions: Acquired Immune Deficiency Syndrome Virus;   Hepatitis C;   Drug Abuse
Intervention: Other: MI-based HIV Risk Reduction
29 Active, not recruiting Keep It Up! 2.0: A Comparison of Two Online HIV Intervention Programs for Young Men Who Have Sex With Men
Conditions: HIV;   Gonorrhea;   Chlamydia
Interventions: Behavioral: Keep It Up!;   Behavioral: HIV Knowledge Control
30 Recruiting Eban II: Intervention for HIV Sero-Discordant Couples
Conditions: Sexually Transmitted Diseases;   Disease Transmission, Infectious;   Safe Sex;   HIV
Intervention: Behavioral: Risk Reduction
31 Completed UCLA-Amity Parolee Health Promotion Study
Conditions: Hepatitis B;   Hepatitis C;   HIV;   Drug Addiction
Interventions: Behavioral: Parolee Comprehensive Care + Phone Coach;   Behavioral: Parolee Brief HBV Program + Phone Coach;   Behavioral: Usual Care Group
32 Recruiting Cabozantinib-S-Malate in Treating Patients With Advanced Solid Tumors and Human Immunodeficiency Virus
Conditions: Advanced Malignant Neoplasm;   HIV Infection;   Metastatic Malignant Neoplasm;   Recurrent Malignant Neoplasm;   Solid Neoplasm;   Unresectable Malignant Neoplasm
Interventions: Drug: Cabozantinib S-malate;   Other: Laboratory Biomarker Analysis;   Other: Pharmacological Study
33 Completed Clinical Monitoring to Facilitate Continuous Care for Substance Abusing Clients
Conditions: Substance-Related Disorders;   Mental Disorders
Intervention: Behavioral: RecoveryTrack - Extended Care (RT-E)

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-33) Next Page   
Study has passed its completion date and status has not been verified in more than two years.